Wallace Bourgeois

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Machine Learning

Allogeneic Hematopoietic Stem Cell Transplantation

Diffuse Large B Cell Lymphoma

Top Venues

Pediatric blood & cancer

Journal of the Endocrine Society

This page only lists publications with an associated author ORCID identifier.

Publications

Wallace Bourgeois, Edward Yang, Roberto Chiarle, Melissa A Burns
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T-lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia. Pediatric blood & cancer (2024)
Wallace Bourgeois, Edward Yang, Roberto Chiarle, Melissa A Burns
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T-lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia. Pediatric blood & cancer 71 (6) (2024)
Brynn E Marks, Ronan P Sugrue, Wallace Bourgeois, A Lindsay Frazier, Stephan D Voss, Marc R Laufer, Catherine M Gordon, Laurie E Cohen
Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome. Journal of the Endocrine Society 5 (9) (2021)